Croyle Recipient of Prestigious Hill Prize

A woman smiling.
February 5, 2024
Professor of Molecular Pharmaceutics and Drug Delivery and Glaxo Wellcome Professor Maria A. Croyle, Ph.D. is a recipient of the prestigious and highly competitive Hill Prize. The prizes, funded by Lyda Hill Philanthropies, accelerate high-risk, high-reward research ideas with significant potential for real-world impact.

Texas Pharmacy Students Clinch Multiple Awards from AFPE

Pharmacy building on UT campus
August 28, 2023
Several graduate students and a Pharm.D. student from The University of Texas College of Pharmacy secured awards and fellowships from the American Foundation for Pharmaceutical Education (AFPE).

Texas Pharmacy Wins Big at Interprofessional Health Showcase 2023

Texas Pharmacy student standing in front of his poster presentation board at the conference.
April 20, 2023
The University of Texas at Austin College of Pharmacy earns accolades for Best in Community Engagement, Best in Health Innovation, Best Project in Progress, Best in Visual and top 3 for People’s Choice Award at the Interprofessional Health Showcase 2023.

Croyle Startup Listed as Finalist for SXSW Innovation Awards

Two hands using tweezers to pull a thin transparent film from its foil packaging.
February 28, 2023
Jurata Thin Film, a startup based on the research discoveries of the College of Pharmacy's Maria Croyle, Ph.D., a professor in the Division of Molecular Pharmaceutics and Drug Delivery, is listed as a finalist in the 2023 SXSW Innovation Awards in Patient Safety. Researchers in Dr. Croyle's lab have developed a peelable lightweight film that stabilizes biologics, is inexpensive and withstands extreme temperature changes. Jurata Thin Film works to bring Dr. Croyle's thin film technology to market.

UT Austin Seed Fund Launched With First Investment to College of Pharmacy Research

A tall clock tower with trees enveloping it in the foreground.
December 1, 2022
The newly-created UT Seed Fund, which will provide funds to the most promising new startups built on university-owned intellectual property, will first invest in Jurata Thin Film, a startup based on the research discoveries of the College of Pharmacy's Maria Croyle, Ph.D., a professor in the Division of Molecular Pharmaceutics and Drug Delivery. Founded in 2019, Jurata has revolutionized the way vaccines and biologics are manufactured, distributed, stored and delivered across the world.

Croyle Wins Best Paper in 2022 Co-op Research Excellence Awards

A woman smiling.
November 4, 2022
Molecular Pharmaceutics and Drug Delivery professor Maria A. Croyle, Ph.D. earned this year's Best Paper Award from the University Co-op Research Excellence Awards, presented by UT's Office of the Vice President for Research, Scholarship and Creative Endeavors and the University Co-operative Society.

AAPS Addresses “Infodemic,” Scientific Credibility and the Public On TV

A man wearing a suit, a man in a patterned shirt smiling, and a woman wearing pearls.
November 4, 2022
Leaders from the American Association of Pharmaceutical Scientists (AAPS), including the College of Pharmacy's Dr. Robert O. (Bill) Williams III, address the “infodemic” and AAPS’ role in evaluating and bringing attention to credible science on a November 5 episode of "Advancements with Ted Danson."

College of Pharmacy Researchers Share Latest Findings on Novel Drug Delivery Technology

Five nasal inhalers with their caps on.
October 31, 2022
Researchers in the lab of Dr. Robert O. (Bill) Williams III, Division Head and Professor of Molecular Pharmaceutics and Drug Delivery at the College of Pharmacy, are advancing an innovative platform technology known as Thin Film Freezing, which could revolutionize administration, distribution and access to both vaccines and therapies.

Croyle Lab Develops Innovative Vaccine Delivery Method

maria croyle vaccine 2020
March 4, 2020
Researchers in the lab of Dr. Maria Croyle have developed a peelable lightweight film that stabilizes biologics, is inexpensive, and withstands extreme temperature changes. The technology has already demonstrated proof of concept for model Ebola and H1N1 vaccines, and may prove an effective method of delivery for future treatments, such as for coronavirus that causes COVID-19.